drugset / Trial / NCT02880280

Human Menopausal Gonadotropin Combining With Human Chorionic Gonadotropin Treat Congenital Hypogonadotropic Hypogonadism

NCT02880280

Phase 4 Unknown 40 enrolled Beijing Children's Hospital
Non-randomizedParallel-groupOpen-labelTreatment

Summary

Observe the therapeutic efficacy of human menopausal gonadotropin combining with human chorionic gonadotropin in adolescent boys with congenital hypogonadotropic hypogonadism.

Timeline

Start
2016-08
Primary completion
2017-08
Completion
2018-12

Drugs

EvaluationDrugModalityDoseRoute
Subject human chorionic gonadotropin Protein / enzyme biologic

Indications